-
Health Canada grants authorisation to Pfizer’s Paxlovid for Covid-19
Pharmaceutical-Technology
January 19, 2022
The authorised dosage is two tablets of nirmatrelvir and one tablet of ritonavir given orally twice daily for five days.
-
Health Canada approves J&J Covid-19 vaccine for use in adults
Pharmaceutical-Technology
November 26, 2021
Health Canada has granted full approval for Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine for active immunisation to prevent infection in adults aged 18 years and older.
-
Health Canada Authorizes the Use of The Moderna Spikevax COVID-19 Vaccine as a Booster Shot
AmericanPharmaceuticalReview
November 17, 2021
Health Canada has authorized the use of the Moderna Spikevax COVID-19 vaccine as a booster shot. A COVID-19 booster shot is an extra dose of the vaccine given after completion...
-
Ocugen commences rolling submission of COVAXIN to Health Canada
pharmaceutical-technology
July 16, 2021
Ocugen has commenced the rolling submission to Health Canada for its Covid-19 vaccine candidate, COVAXIN, which is being jointly developed with Bharat Biotech International for use in the US and Canada.
-
MHRA and Health Canada release new clinical safety reporting guidance
europeanpharmaceuticalreview
July 08, 2021
Under the new guidance, Development Safety Update Reports must include a description of the process used to review the worldwide safety data of the investigational drug.
-
Health Canada to modernise its clinical trial regulations
europeanpharmaceuticalreview
June 17, 2021
Health Canada has proposed a single regulatory framework for clinical trials for all health products that will support innovation and streamline drug and medical device development.
-
Health Canada approves Pfizer and BioNTech’s Covid-19 vaccine for adolescents
pharmaceutical-technology
May 07, 2021
With Health Canada authorisation, the Pfizer and BioNTech vaccine became the first-of-its-kind indicated for this age group to receive approval in the country.
-
Health Canada to review rolling submission for Medicago’s Covid-19 vaccine
pharmaceutical-technology
April 27, 2021
Health Canada has accepted for review the first portion of the rolling submission by Medicago for its plant-derived adjuvanted Covid-19 vaccine candidate.
-
Bora Pharmaceuticals Completes Health Canada Inspection
contractpharma
April 25, 2021
Mississauga site is the company’s first manufacturing facility in North America and is its HQ in the region.
-
Health Canada authorises J&J’s Covid-19 vaccine for emergency use
pharmaceutical-technology
March 09, 2021
Health Canada has authorised an Interim Order (IO) to the Janssen Pharmaceutical (JPI) Companies of Johnson & Johnson’s (J&J) single-shot vaccine preventing Covid-19 for people aged 18 above.